Alexey Vinogradov
Head of Pharmstandard Ventures
Head of Pharmstandard Ventures
PHS VENTURES
Russian Federation
Biography
Dr Vinogradov has over 15 years of experience at different positions in biotech industry, including R&D, operations, management and business development. He has served as a Board member at Argos Therapeutics and Board observer at Protagonist Therapeutics and Aquinox Pharmaceuticals, and currently serves as Board member at Avelas Biosciences and Board observer at Allena Pharmaceuticals. Prior to joining Pharmstandard Ventures (formerly Inbio Ventures) in 2012 as co-founding partner and CBO, Dr. Vinogradov was involved in portfolio building at Bioprocess Capital Partners, Russia's first specialized life sciences Venture fund. He led the fundraising and served in executive management at Promogene, Tartis-oncology and Everon. In addition, Dr. Vinogradov was involved in the range of business development activities at Bioprocess Group, one of the pioneers at Russian biosimilars market (more recently acquired by Pharmstandard). Dr Vinogradov held postdoctoral position at the Laboratory of Biomolecular Sciences, Wageningen University, the Netherlands. He obtained his PhD degree in biochemistry and MS degree in chemistry from Moscow State University.
Research Interest
Dr Vinogradov has over 15 years of experience at different positions in biotech industry, including R&D, operations, management and business development. He has served as a Board member at Argos Therapeutics and Board observer at Protagonist Therapeutics and Aquinox Pharmaceuticals, and currently serves as Board member at Avelas Biosciences and Board observer at Allena Pharmaceuticals. Prior to joining Pharmstandard Ventures (formerly Inbio Ventures) in 2012 as co-founding partner and CBO, Dr. Vinogradov was involved in portfolio building at Bioprocess Capital Partners, Russia's first specialized life sciences Venture fund. He led the fundraising and served in executive management at Promogene, Tartis-oncology and Everon. In addition, Dr. Vinogradov was involved in the range of business development activities at Bioprocess Group, one of the pioneers at Russian biosimilars market (more recently acquired by Pharmstandard). Dr Vinogradov held postdoctoral position at the Laboratory of Biomolecular Sciences, Wageningen University, the Netherlands. He obtained his PhD degree in biochemistry and MS degree in chemistry from Moscow State University.
